Obesity Drug Zepbound Approved for Obstructive Sleep Apnea
The US Food and Drug Administration (FDA) has approved the obesity treatment tirzepatide (Zepbound, Eli Lilly) for treating moderate to ...
Day: December 24, 2024
Hospitals trial AI to spot type 2 diabetes risk
Two NHS hospital trusts in London are using AI technology to see if they can spot type 2 diabetes in ...
Why Sex and Gender Are Important Biomarkers in PsA
NEW YORK — Rheumatologists, dermatologists, drug manufacturers, and researchers do not pay enough attention to the role sex and gender ...
Slow-Paced Martial Arts Drives Sustained Activity in Older Adults
TOPLINE:Older adults with mild cognitive impairment or memory concerns increased their physical activity by an average of 65 minutes per ...
Breast Cancer Screening Shows Gaps in Women Aged 40-49 Years
TOPLINE:Among 20.1 million women aged 40-49 years, only 59.2% underwent biennial mammography screening, with significantly lower rates observed in racial ...
Q&A With NIH Dermatology Consultation Service Director
Edward W. Cowen, MD, MHSc, senior clinician at the National Institute of Arthritis and Musculoskeletal and Skin Diseases, leads the ...
Psoriasis Affects an Estimated 3% of US Adults
TOPLINE:Approximately 3% of adults in the United States have psoriasis, with a higher prevalence among older adults, individuals with overweight ...
People seek NHS advice on drinking and breastfeeding at Christmas
NHS website information on drinking while breastfeeding saw the highest increase in visits at Christmas last year, new figures show. ...
Combining Retinal Scanning and Liver Screening in T2D
TOPLINE:Simultaneous screening for liver fibrosis during retinal scanning shows promise as a novel pathway for detecting advanced liver disease in ...
AI Catches Missing MRI Lesions
LOS ANGELES — An open-source artificial intelligence (AI) module can help identify epileptic lesions on MRI missed by human reviewers, ...
